← Back to headlines
Big Pharma Eyes Biotech Acquisitions as Oncology M&A Heats Up
As mergers and acquisitions in the oncology sector intensify, five biotech companies are identified as potential targets for acquisition by larger pharmaceutical firms.
1 Apr, 11:05 — 1 Apr, 11:05
Sources
Showing 1 of 1 sources
